Table 5.
Advantages |
High activity against P. aeruginosa including MDR strains |
|
Predictable PK |
|
Good safety profile and tolerability |
|
Carbapenem sparing |
|
Rapid tissue distribution |
|
Disadvantages |
|
Increased costs |
|
No oral formulations to allow step-down therapy |
|
Superinfection with even more resistant bacteria or fungi |